Abstract -Cardiac microvascular injury often occurs in patients with type 2 diabetes mellitus (T2DM) who develop hyperglycemia and hyperlipidemia. However, besides reported contradictory roles in cardiac diseases, the function of TRPV1 (transient receptor potential vanilloid 1) in cardiac microvessels is not well defined. This study was performed to determine the detailed role of TRPV1 in cardiac microvascular endothelial cells (CMECs) in T2DM. T2DM mice were established by multiple injections of low-dose streptozotocin and high-fat feeding. CMECs were cultured separately in mediums of normal glucose, high glucose (HG), high fatty acid (HF), and HG plus HF (HG-HF 
T ype 2 diabetes mellitus (T2DM) is currently among the top 10 causes of death worldwide, with an estimated prevalence of 9% among adults. 1 In addition to typical glucose metabolism abnormalities, T2DM is commonly associated with abnormal serum lipid levels, and the percentage of hyperlipidemia is as high as 67.1% in T2DM. 2 Diabetic patients are largely affected by vascular abnormalities involving multiple organ systems, and these can be divided into microvascular and macrovascular complications with respective clinical symptoms. 3 Cardiovascular disorders are the leading cause of morbidity and mortality in the diabetic population and result in a heavy financial burden to families and society. 4 Convincing evidence suggests that endothelial apoptosis occurs early in T2DM. 5 Many studies have shown that microvascular endothelial cells possess some unique properties in secretion, blood feeding, and even biological metabolism. 6 Cardiac microvascular dysfunction leads to an imbalance between myocardial oxygen supply and demand, as in epicardial coronary stenosis. 7 Microvascular angina, also called cardiac syndrome X, is a distinct clinical entity caused by cardiac microvascular dysfunction and is typically because of impaired vasodilatation of cardiac microvessels. 8 Unfortunately, cardiac microvascular endothelial cells (CMECs) have not been well studied in the diabetic heart, not even for targeted treatment.
TRPV1 (transient receptor potential vanilloid 1) plays critical roles in metabolic homeostasis and cardiovascular function by regulating intracellular Ca 2+ levels. 9 TRPV1 blockage induced by T2DM is related to poor recovery of cardiac function after myocardial ischemia. 10 As a natural and specific agonist for TRPV1 channels, capsaicin is used for treating diabetic peripheral neuropathy and arthritis. 11 Encouragingly, capsaicin is associated with a lower prevalence of cardiovascular disease. 12 The protective effects of capsaicin on the cardiovascular system are related to enhanced amelioration of atherosclerosis, 13 reversed cardiac hypertrophy, 14 and improvement of coronary dysfunction and a prolonged lifespan in atherosclerotic mice. 15 However, some studies have suggested that TRPV1 deficiency in the heart improves cardiac function during ischemia/reperfusion. 16 Motter and Ahern 17 even reported that TRPV1-null mice had better weight control when fed high fat for a prolonged period of time. Riera et al 18 also showed a strong association between TRPV1 deletion and longevity. In view of the above-mentioned contradictory roles of TRPV1 in cardiovascular disease, this issue needs to be examined from different perspectives. To date, the characteristics of TRPV1 in diabetic CMECs have not been fully elaborated, and the underlying molecular mechanism requires further investigation.
Oxidative stress is defined as a state in which the reactive oxygen species (ROS) content in vivo exceeds the buffering capacity of antioxidant enzymes and antioxidants, resulting in a local imbalance between production and destruction of ROS. 19 T2DM is associated with increased intracellular ROS, which induces apoptotic cell death in endothelial cells. 20 Moreover, ROS overload has been identified as a major mediator of endothelial dysfunction in T2DM, leading to abnormal cardiovascular events. 21 As a protein located in the inner mitochondrial membrane, OPA1 (optic atrophy 1) is critically responsible for mitochondrial fusion. A reduction in OPA1 leads to abnormalities in mitochondrial organization, depressed mitochondrial respiration, and increased ROS generation.
22
T2DM significantly reduces OPA1 expression in coronary endothelial cells. 23 Low expression and pathogenic mutation of OPA1 can increase sensitivity of apoptosis in mouse embryonic fibroblasts. 24 Recent research has even shown that TRPV1 activation attenuates hyperglycemia-induced endothelial dysfunction in the carotid artery via UCP2 (uncoupling protein 2)-mediated oxidation resistance. 25 However, whether TRPV1 exerts antioxidant effects on diabetic CMECs is still unknown, and the precise role of OPA1 in this process is also unclear.
Therefore, the present study was performed to determine the following: (1) whether TRPV1 is disturbed in diabetic CMECs, (2) whether TRPV1 deficiency affects survival and function of CMECs in T2DM, and if so, (3) whether OPA1-mediated suppression of oxidative stress participates in TRPV1's microvascular protection.
Materials and Methods

Experimental Procedures
The authors declare that all supporting data are available within the article (and its online-only Data Supplement).
Preparation of Mice
Normal C57BL6/J mice (male, 6 weeks old) were obtained from Vital River (Beijing, China). TRPV1 −/− mice were purchased from Jackson Laboratory (Bar Harbor, ME). Mice were housed under a 12/12-hour light-dark cycle with free access to food and water. A 2-week adaptation time was allowed before any procedures. All experiments were performed in adherence with the National Institutes of Health Guidelines on the Use of Laboratory Animals and were approved by Chengdu Military General Hospital Committee on Animal Care.
Preparation of CMECs
CMECs were isolated from hearts of wild-type (WT) and TRPV1 −/− mice using collagenase as previously described 26 and identified with staining by von Willebrand factor and CD31. After adherence of cells, media were separately replaced with normalglucose medium (Normal; 5.5 mmol/L), high-glucose medium (HG; 25 mmol/L), high fatty acid (HF; 1 mmol/L), and HG plus HF (HG-HF). HF was mixed ingredients, which consists of oleic acid (16:0, 0.66 mmol/L) and palmitic acid (18:1, 0.33 mmol/L; molar ratio 2:1; Sigma-Aldrich, Milan, Italy). 27 CMECs were treated with Normal, HG, HF, or HG-HF for 24 hours in the presence or absence of selected pharmacological reagents, including capsaicin, 1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA; 20 µmol/L; Sigma-Aldrich), 5′-iodoresiniferatoxin (iRTX; 1 µmol/L; Abcam, Cambridge, United Kingdom), hydrogen peroxide (H 2 O 2 ; 400 µmol/L; Kelun Pharmaceutical, Chengdu, China), and lentivirus vector carrying the OPA1 sequence (1×10 9 TU/mL; GeneChem, Shanghai, China). The OPA1 gene was subcloned into the lentivirus vector, also encoding GFP (green fluorescence protein), to construct OPA1 supplementation (lowlevel overexpression of OPA1). Cells were infected with OPA1 supplementation or GFP (lentivirus vector only encoding GFP) in serum-free medium for 4 hours. The medium was then changed with Normal-containing serum for 72 hours and finally incubated with HG-HF for 24 hours.
Assessment of Cardiac Function
To evaluate left ventricular diastolic function, we detected the peak flow velocity of the early rapid diastolic filling wave and late diastolic filling wave and calculated the ratio of the early mitral diastolic wave/late mitral diastolic wave. The Vevo 2100 ultrasound device (VisualSonics, Toronto, Canada) was used to measure the left ventricular end-diastolic diameter and fractional shortening on M-mode tracings.
Determination of Cardiac Glucose Metabolism
We determined whole-body 18 F-fluorodeoxyglucose ( 18 F-FDG) uptake by NanoScan positron emission tomography/computed tomography scanning (Mediso Medical Imaging Systems, Budapest, Hungary) as described previously. 28 The data were reconstructed over a 175×175×118 matrix with 0.77-mm slice thickness. Relative accumulation of the radioactivity in particular regions was expressed as percentage of the injected dose per gram of the tissue (ID%/g).
Examination of Cardiac Microvascular Integrity
A vascular cast was made to assess microvascular endothelial integrity within the vessel wall of the heart using scanning electron microscopy. 29 Mice received 10 mL of low-viscosity resin mixed with benzoyl peroxide as a catalyzer at a perfusion pressure of ≤100 mm Hg through the aorta and were corroded in a solution consisting of 5% sodium hydroxide solution at room temperature. After removal of all connective tissues surrounding the blood vessels, regular pretreatments in accordance with standard instructions were used. Cardiac microvessels (vessel diameter of <500 μm) were subsequently observed by scanning electron microscopy (Hitachi S-3400N; Hitachi) using corrosion casts.
Immunohistochemistry
The samples were fixed in 4% paraformaldehyde at room temperature for 30 minutes, rinsed with PBS, and incubated with blocking buffer (20% fetal calf serum and 0.1% Triton X-100 in PBS) at room temperature for 2 hours. Cultures were incubated with primary antibodies (von Willebrand factor antibody, 1:200; Abcam and TRPV1 antibody, 1:100; Novus Biologicals, Littleton, CO) at 4°C overnight, followed by detection with corresponding fluorescent secondary antibodies for 1 hour at 37°C. Finally, nuclei were counterstained with 4′,6-diamidino-2-phenylindole (5 µg/mL; Beyotime, Jiangsu, China). Samples were examined by laser scanning confocal microscopy (LSCM; Olympus FV 1000; Olympus, Tokyo, Japan). 
Measurement of Intracellular
Measurement of Nitric Oxide
CMECs were washed twice in Hanks' balanced salt solution before adding Hanks' balanced salt solution containing 4,5-diaminofluorescein diacetate (a nitric oxide (NO)-sensitive fluorescent dye, 10 µmol/L; Calbiochem, Germany). 31 After further incubation for 30 minutes in a dark room, the cells were rinsed in Hanks' balanced salt solution. 4,5-diaminofluorescein diacetate fluorescence was monitored using LSCM. NO was also determined by using the NO ELISA kit (Elabscience).
Quantification of ROS and Nitrotyrosine
ROS production in viable CMECs was measured by lucigeninenhanced chemiluminescence assay following a previous method. 32 ROS production was expressed as relative light units per second per million cells. Dihydroethidine staining was used to detect the in situ formation of superoxide according to oxidative fluorescent microtopography. 33 Dihydroethidine staining was visualized under LSCM and analyzed with Image-Pro Plus 6.0 (Media Cybernetics, Rockville, MD). ROS was also determined by using the ROS ELISA kit (Elabscience). Nitrotyrosine, a footprint of in vivo peroxynitrite formation and an index of nitrative stress, was also quantified using an ELISA kit (Millipore, Billerica, MA).
Assessment of Mitochondrial Membrane Potential
Variations in mitochondrial potentials were quantitated by the JC-1 (JC-1 Mitochondrial Membrane Potential Assay Kit, Invitrogen) test. CMECs were seeded on gelatin-coated culture chamber slides, stained with JC-1 (5 μmol/L) at 37°C for 10 minutes, and rinsed with HEPES-saline buffer. Fluorescence (excitation wavelength [Ex]=490 nm; emission wavelength [Em]=530 and 590 nm) was read by a Spectro-fluorometer (Spectra Max, Atlanta, GA). Fluorescence intensity values were expressed as ratios of emission at 590:530 nm.
Measurement of Mitochondrial ATP Content
A firefly luciferase-based ATP assay kit (Beyotime, China) was used to measure ATP content in CMECs according to the manufacturer's instructions. After being homogenized and centrifuged, supernatants were mixed with the ATP detection working solution in a white 96-well plate. Standard curves were generated, and protein concentration was determined using the Bradford protein assay. Total ATP levels were expressed as nmol/mg protein.
Assessment of Apoptosis
Apoptosis was detected by the Annexin V-FITC Apoptosis Detection Kit (fluorescein isothiocyanate; GenScript, Piscataway, NJ) according to the manufacturer's instructions. After cells were harvested and washed with PBS, the cells were separately stained with annexin V-FITC staining solution and propidium iodide at room temperature. Annexin V-FITC binding was detected by an FITC signal detector (Ex=488 nm; Em=530 nm). Propidium iodide staining was detected by a phycoerythrin emission signal detector (Ex=488 nm; Em=620 nm) in a flow cytometer (Becton Dickinson, Franklin Lakes, NJ). The index of apoptosis was expressed as the proportion of FITC and propidium iodide staining.
Determination of mRNA Expression
Total RNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA) from CMECs after treatment with different reagents. Quantitative real-time polymerase chain reaction was performed with TaKaRa SYBR Premix ExTaq on the Bio-Rad IQ5 Multicolor Real-Time Polymerase Chain Reaction Detection System (Bio-Rad Laboratories, Hercules, CA) following standard protocols. Primer sequences are shown in Table S1 in the online-only Data Supplement.
Determination of Protein Expression
After CMECs were harvested at the indicated times, equal amounts of total protein (≈20 μg) from CMECs were separated by SDS-PAGE and then transferred to nitrocellulose (Millipore). After blocking with 5% skim milk, the membranes were incubated with the appropriate primary antibody overnight. The following antibodies were used: TRPV1 (1:2000; Novus Biologicals), OPA1 (1:2000; Abcam), and GAPDH (1:2000; Cell Signaling Technology, Danvers, MA). Secondary antibodies were horseradish peroxidase-conjugated goat anti-rabbit IgG and rabbit anti-mouse (Santa Cruz Biotechnology, Dallas, TX) at 1:5000 dilution. 19 The blots were visualized using chemiluminescence and quantified using Image-Pro Plus 6.0 (Media Cybernetics).
Statistical Analysis
All data are expressed as mean±SEM and were analyzed using ANOVA, followed by Bonferroni correction for the post hoc t test (except for Western blot data). Western blot results were analyzed with the Kruskal-Wallis test, followed by Dunn post hoc test. A value of P<0.05 was considered to be statistically significant. All statistical tests were performed by using Graph Pad Prism software version 6.0 (GraphPad Software, La Jolla, CA).
Results
TRPV1 Expression Is Inhibited by HG-HF in CMECs
Impairment of TRPV1 channels may contribute to vascular dysfunction in diabetes mellitus. To validate the characteristics of TRPV1 in the endothelium, CMECs were isolated from cardiac microvessels in WT and TRPV1 −/− mice hearts and cultured in Normal, HG, and HG-HF medium. CMECs tested positive for von Willebrand factor and CD31 ( Figure S1A ) and showed flagstone morphology ( Figure S1B ), indicating that they were CMECs. Intrinsic fluorescence showed TRPV1 protein in CMECs and cardiac microvessels ( Figure 1A ; Figure  S1C ). Moreover, there was a substantial decrease in TRPV1 mRNA and protein expression with exposure to HG-HF as determined by quantitative real-time polymerase chain reaction, Western Blotting, and immunofluorescence staining ( Figure 1A through 1C ] i in CMECs was significantly decreased ( Figure 1D ; Figure S2 ). These data suggest that HG-HF is able to disturb [Ca 2+ ] i by reducing TRPV1 expression in CMECs.
TRPV1 Deficiency Aggravates Cardiac Microvascular Injury Induced by T2DM and Worsens Functional Impairment and Cellular Apoptosis Induced by HG-HF
To investigate the potential function of TRPV1, WT and TRPV1 −/− mice were used in our experiments ( Figure S3 ).
After 24 weeks of sustained high-fat diet, T2DM models with hyperglycemia and hyperlipidemia were successfully established (Table S2 ). Mice were anesthetized to determine cardiac function using echocardiography. TRPV1
−/− mice showed more severe impairment of diastolic function under T2DM, as shown by a decreased early mitral diastolic wave/late mitral diastolic wave (E/A) ratio, compared with WT mice; however, there was little difference in fractional shortening among the groups (Figure 2A ). The 18 F-FDG method has been widely used in experimental and clinical settings to quantify cardiac glucose metabolism. To determine the specific effects of TRPV1 −/− on the diabetic heart, 18 F-FDG was used to analyze changes in cardiac glucose metabolism. T2DM led to defective 18 F-FDG uptake in the heart. TRPV1 knockout had a lower level of glucose uptake than WT mice ( Figure 2B ). Furthermore, scanning electron microscopy was used to evaluate cardiac microvascular integrity. In controls, the surface of cardiac microvessels was smooth and well integrated. However, numerous irregular evaginations and invaginations were identified in cardiac microvessels in T2DM. More importantly, TRPV1 deficiency aggravated cell junction impairment in microvessels, as shown by more irregular and rougher images than WT ( Figure 2C ). Collectively, TRPV1 ablation leads to impaired diastolic function and abnormal glucose metabolism in the diabetic heart, which may be because of cardiac microvascular injury.
To confirm the causal role of TRPV1 in CMECs, NO production was measured and cell survival was assessed. We found that both of HG and HF could significantly reduce NO generation. The insult of HG-HF resulted in a greater reduction of NO content than HG and HF alone ( Figure 2D and 2E) . Moreover, HG-HF led to a higher apoptosis rate of CMECs ( Figure 2F ; Figure S4 ). More importantly, TRPV1 ablation in CMECs not only further inhibited NO generation but also exacerbated endothelial apoptosis, in response to HG and HF alone, as well as HG-HF (Figure 2D through 2F ; Figure  S4 ). Taken together, these results demonstrate that TRPV1 in CMECs plays a critical role in endothelial function and cell survival under the condition of HG-HF. 
TRPV1 Knockout Enhances HG-HF-Induced Oxidative/Nitrative Stress and Mitochondrial Dysfunction
Oxidative stress plays an important role in the pathogenesis of diabetic microvascular complications, and TRPV1 might exert an antioxidant effect on vascular endothelium under HG. To determine whether TRPV1 has an antioxidant role in CMECs, ROS and nitrotyrosine were measured. As shown in Figure 3A through 3C, both of HG and HF increased generation of ROS and nitrotyrosine in CMECs after 24 hours of ; echocardiographic analysis of the early mitral diastolic wave/late mitral diastolic wave (E/A) ratio (middle) was used to reflect left ventricular diastolic function; and left ventricular fractional shortening (FS; right) was used to assess left ventricular systolic function. B, Representative positron emission tomography (PET)/ computed tomography (CT) scanning images (left) were taken to reflect cardiac glucose uptake and quantification of accumulated 18 F-fluorodeoxyglucose (18F-FDG; right) in the heart was analyzed. C, Scanning electron microscopy was used to assess microvascular endothelial integrity within the vessel wall of the heart. D, NO production in CMECs was detected by staining with 4,5-diaminofluorescein diacetate (DAF-2DA) and observed with laser scanning confocal microscopy. E, Production of NO was measured by an ELISA kit. incubation, and HG-HF further enhanced oxidative/nitrative stress. More than that is the suppression of mitochondrial function, such as decreased ATP production and mitochondrial membrane potentials under this condition ( Figure 3D and 3E). Moreover, under the condition of HG, HF, and HG-HF, TRPV1 knockout led to more generation of ROS and nitrotyrosine, as well as worse mitochondrial function. Furthermore, CMECs were exposed to H 2 O 2 to investigate the relationship between TRPV1 and oxidative stress. After treatment with H 2 O 2 for 12 hours, TRPV1 expression was markedly inhibited ( Figure 3F ). These data suggest that ROS overload and TRPV1 blockage form a vicious circle in CMECs, and biological rebalance of TRPV1 may be an effective therapy to rescue diabetic CMECs.
OPA1 Supplementation Partly Reverses the Detrimental Effects Induced by TRPV1 Knockout in Diabetic CMECs
To determine the role of mitochondrial protein in diabetic CMECs, endothelial mRNA was scanned ( Figure  S5 ). Compared with HG and HF alone, OPA1 mRNA and protein expression was more significantly suppressed by HG-HF and was further disturbed by TRPV1 knockout; moreover, PGC-1α (peroxisome proliferator-activated receptor-γ coactivator-1α) mRNA and protein expression was also decreased obviously by TRPV1 deficiency in response to HG-HF ( Figure 4A ). To clarify the mode of TRPV1's action on PGC-1α/OPA1 expression, the change in [Ca 2+ ] i in CMECs was determined. Capsaicin was used to trigger TRPV1 activation in WT or TRPV1 −/− CMECs, and then other reagents were administrated separately. OPA1 and PGC-1α expression was inhibited in WT CMECs after combination with iRTX or BAPTA, as well as in TRPV1 −/− CMECs ( Figure 4B ). These results indicate that TRPV1 may regulate mitochondrial biogenesis in a Ca 2+ -dependent manner. To confirm the specific role of OPA1 in CMECs, we introduced lentiviral vector carrying the OPA1 gene, which had been successfully constructed and maintained at a high expression to a certain extent ( Figure S6A and S6B) . In TRPV1 −/− CMECs under the condition of HG-HF, OPA1 supplementation not only greatly improved mitochondrial function, as evidenced by increased mitochondrial membrane potentials, and reduced generation of ROS and nitrotyrosine, but also promoted the survival and function of CMECs (Figure 4C through 4F ; Figure S6C ). Therefore, mitochondrial OPA1 may serve as an indispensable molecule downstream of TRPV1 in CMECs by preventing oxidative/nitrative stress.
Capsaicin Alleviates Diabetic Injury in CMECs via PGC-1α/OPA1 Signaling
Capsaicin treatment for diabetes mellitus significantly increased mRNA expression of TRPV1, PGC-1α, and OPA1 in WT CMECs, but not in TRPV1 −/− ( Figure 5A ). Figure 5B through 5D) . Consistently, capsaicin not only reduced apoptosis of CMECs but also promoted the capacity of NO generation in viable CMECs; however, TRPV1 deficiency eliminated the protective effects of capsaicin in CMECs ( Figure 5E and 5F). In conclusion, TRPV1 activation by capsaicin may protect against diabetic CMECs injury via suppressing oxidative/nitrative stress mediated by PGC-1α/ OPA1 signaling.
Long-Term Diet of Capsaicin Attenuates Cardiac Microvascular Injury in T2DM
In the T2DM mice, after 24 weeks of persistent capsaicin feeding, capsaicin improved cardiac diastolic function, but not fractional shortening in diabetic mice, compared with vehicle feeding. Notably, such effects were absent in TRPV1 −/− mice ( Figure 6A ). Moreover, chronic treatment of capsaicin greatly improved glucose uptake in the diabetic heart, whereas TRPV1 deficiency showed less myocardial 18 F-FDG uptake with administration of capsaicin ( Figure 6B ). Furthermore, dietary capsaicin in T2DM effectively attenuated cardiac microvascular injury depending on TRPV1 in a pronounced manner ( Figure 6C ). Long treatment of capsaicin also attenuated myocardial fibrosis in the diabetic heart, whereas little changes have taken place in TRPV1 deficiency ( Figure S7 ). These findings suggest that chronic activation of endothelial TRPV1 by dietary capsaicin is able to improve cardiac diastolic function, promote cardiac glucose uptake, mitigate cardiac microvascular injury, and inhibit myocardial fibrosis in T2DM.
Discussion
In this study, we observed the protective effects of endothelial TRPV1 channels and the mitochondrial fusion protein OPA1 on the diabetic heart. We found an unexpected functional association between cardiac microvascular injury and oxidative/nitrative stress in T2DM, both in vitro and in vivo. First, we found that HG-HF reduced TRPV1 expression in CMECs and that TRPV1 deficiency aggravated cardiac microvascular injury in T2DM. Second, we provided evidence that TRPV1 knockout enhanced oxidative/nitrative stress in diabetic CMECs, and in turn, ROS overload was able to block TRPV1 channels. These findings suggest that there is a vicious cycle between TRPV1 blockage and ROS generation. Third, we showed that the protective effects of TRPV1 occurred in a Ca 2+ /PGC-1α/OPA1-dependent manner. Fourth, we found that a long-term diet of capsaicin rescued cardiac microvascular injury in mice with T2DM.
Accumulating evidence has shown that diabetic microvascular injury plays an important role in cardiac dysfunction. 34 Tight control of cardiac microvascular function is essential for maintaining circulatory homeostasis and the physiological function of the heart. 35 We found that HG-HF not only induced more apoptosis of CMECs but also led to less NO generation than HG and HF in surviving CMECs. Moreover, by establishing a mouse model of T2DM, especially with hyperlipidemia, we found that T2DM led to obvious cardiac microvascular injury. This injury was shown by damaged endothelial integrity, reduced myocardial glucose metabolism, and impaired cardiac diastolic function. These results suggested that physicians should pay more attention to the management of dyslipidemia in patients with T2DM. If these pathological conditions are poorly managed, the incidence of cardiovascular disease will be higher. In line with our results, the United Kingdom Prospective Diabetes Study showed that an increased concentration of lowdensity lipoprotein cholesterol was the greatest adverse risk factor for myocardial infarction. 36 The 2011 expert consensus in China stated that the prevalence rate of dyslipidemia was as high as 78.51% in patients with T2DM, the awareness rate was 55.5%, the overall treatment rate was only 44.8%, and the overall control rate was merely 11.6%. This consensus suggested that the management of dyslipidemia in patients with T2DM is not ideal in China. Cardiac microvascular abnormalities can cause ischemia and lead to an increased risk of cardiovascular events. Sara et al 37 found that patients with chest pain and nonobstructive coronary artery disease had a higher prevalence of cardiac microvascular abnormalities. In addition, these abnormalities were poorly correlated with conventional cardiovascular risk factors and dissociated from the findings of noninvasive functional testing. Recent data have shown that statins may improve symptoms of angina and exercise tolerance in patients with syndrome X, likely because of improvement of endothelial vasodilator function. 38 This finding is consistent with the 2016 ESC/EAS Guidelines (European Society of Cardiology/ European Atherosclerosis Society), in which statins were strongly recommended for most patients with diabetes mellitus aged ≥40 years to manage dyslipidemia where appropriate. 39 Capsaicin is the pungent ingredient of chili pepper and has become an indispensable condiment in daily nutrients. Capsaicin can be passively absorbed with high efficiency in the upper gastrointestinal tract, transported by albumin in the blood, and initiate a series of physiological effects in different organs or tissues. 40 Known as a capsaicin receptor and a thermoregulatory channel response to noxious stimuli, TRPV1 is able to protect myocardial tissues against cold stress-associated dysfunction. 41 Emerging evidence has suggested that TRPV1 plays protective roles in cardiovascular function. 42 However, some studies have shown that TRPV1 is associated with the development of cardiac hypertrophy and heart failure. 43 In view of the above-mentioned contradictory roles of TRPV1 in cardiovascular disease, the issue needs to be solved from a different perspective. In our study, TRPV1 expression was inhibited in diabetic CMECs, and its reduction came along with decreased cellular Ca 2+ content, indicating its vital role in CMECs. In TRPV1 −/− mice, we observed deleterious effects induced by TRPV1 deficiency as shown by impaired cardiac diastolic function, abnormal myocardial glucose metabolism, and fragmentary cardiac microvessels. Chronic activation of TRPV1 by a capsaicin diet attenuated the microvascular barrier defect, cardiac glucose metabolism, diastolic function, and myocardial fibrosis in diabetic hearts. In line with our results, TRPV1 activation has been reported to attenuate hypertension in mesenteric artery endothelial cells. 44 Our study provides strong evidence supporting the protective effects of TRPV1 against diabetic microvascular defects and diabetic myocardial fibrosis.
Despite the knowledge that oxidative stress closely interacts with mitochondrial dysfunction, the detailed mechanisms remain unclear. Therefore, we examined the specific role of oxidative stress in diabetic CMECs. In our study, combination of HG and HF further enhanced oxidative/nitrative stress in WT CMECs, accompanied with mitochondrial impairment, which was aggravated in TRPV1 −/− CMECs. Collectively, TRPV1 has a protective role in the development of cardiac microvascular injury induced by T2DM via inhibiting oxidative/nitrative stress. Furthermore, a declining trend in TRPV1 after treatment with H 2 O 2 suggested that ROS overload and TRPV1 inhibition formed a vicious circle in CMECs. Biological rebalance of ROS and TRPV1 may be an effective therapy for rescuing diabetic CMECs.
As a principal regulator for genes involved in mitochondrial biogenesis and lipid metabolism, PGC-1α serves as a prospective target for metabolic modulation therapies in diabetes mellitus and cardiomyopathy. 45 TRPV1 activation is able to improve energy metabolism and exercise endurance by upregulating PGC-1α in skeletal muscles. 46 Our study proved that TRPV1 activation upregulated PGC-1α expression in WT CMECs, but not in TRPV1 −/− .To determine the underlying pathway responsible for the above-mentioned alterations, we further detected mitochondrial protein OPA1 which had been considered as a major mediator for oxidative stress in cellular injury. 47 In our study, exposure of CMECs to diabetic condition exacerbated mitochondrial dysfunction and inhibited OPA1 expression, which is consistent with results reported by Lu et al. 48 In some rodent studies, capsaicin-rich diets have shown favorable effects on hypertension, metabolic syndrome, and diabetes mellitus. Our study showed that TRPV1 activation enhanced OPA1 expression in WT CMECs, but not in TRPV1 −/− CMECs. We also found that the antioxidative stress effect of TRPV1 was interrupted after blocking TRPV1 channel, chelating Ca 2+ , and knocking out gene separately. Moreover, abnormalities in mitochondrial fission and fusion are linked to the pathophysiology of diabetes mellitus. 49 Suppression of mitochondrial fission is able to recover mitochondrial function and preserve CMECs barrier function by reducing ROS generation. 50 Meanwhile, mitochondrial fusion protein OPA1 can reduce cell apoptosis by maintaining mitochondrial integrity and preventing cytochrome c release. 51 Consistently, we confirmed that OPA1 supplementation improved mitochondrial function and rescued CMECs in the absence of TRPV1. Therefore, in diabetic CMECs, mitochondrial protein OPA1 plays an important role in TRPV1's protection. Clinical investigations have indicated that restoration of endothelial function in patients normally takes 6 months or even longer. 52 In our study, we administered capsaicin for 6 months in the T2DM mice. We found that chronic activation of TRPV1 by capsaicin attenuated microvascular barrier defects, improved cardiac glucose metabolism and function, and reduced myocardial fibrosis in the diabetic heart in WT mice, but not in TRPV1 −/− , consistent with a previously reported animal model of metabolic syndrome. 53 Thus, capsaicin may attenuate cardiac microvascular injury induced by T2DM through activating TRPV1/Ca 2+ / PGC-1α/OPA1 pathway.
In conclusion, our study shows that the protective effects of TRPV1 for cardiac microvessels are dependent on Ca 2+ / PGC-1α/OPA1 signaling in T2DM ( Figure 6D ). TRPV1 activation through chronic dietary capsaicin may represent a promising lifestyle intervention in high-risk populations with diabetic microvascular injury and related vascular disorders.
Perspectives
Cardiac microvascular injury plays an important role in diabetic cardiovascular dysfunction causing morbidity and mortality in patients with T2DM. Mitochondria are an important source of ROS, while excessive ROS act as the major mediators of mitochondrial dysfunction in turn and further result in endothelial dysfunction. We conducted experiments to distinguish that chronic activation of TRPV1 has a protective role in the development of cardiac microvascular injury via inhibiting oxidative/nitrative stress when facing to T2DM. Moreover, our study provided strong evidence supporting the protective effects of OPA1 against diabetic mitochondrial dysfunction and CMECs injury, pointing at TRPV1/Ca 2+ /PGC-1α/OPA1 as a novel target for the treatment of diabetic microvascular injury in heart.
